• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短期试验数据的解读:对化学预防活性评估的意义

Interpretation of short-term test data: implications for assessment of chemopreventive activity.

作者信息

Waters M D, Stack H F, Jackson M A, Brockman H E

机构信息

US Environmental protection Agency, Research Triangle Park, NC 27711, USA.

出版信息

IARC Sci Publ. 1996(139):313-32.

PMID:8923041
Abstract

The same short-term tests that have been used extensively to identify mutagens and potential carcinogens are increasingly being used to identify antimutagens and potential anticarcinogens. It is not yet known whether the inhibition of carcinogen-induced mutation is a good indicator of anticarcinogenicity, as the available data on the inhibition of both carcinogenicity and mutagenicity In vivo are still quite incomplete. Furthermore, in vitro tests will detect only those compounds that show an effect that is demonstrable in vitro, such as direct inhibition of the metabolism of the carcinogen or inactivation of the carcinogen by direct reaction. Thus it is essential to confirm putative antimutagenic activity observed in vitro through the use of animal models. Indeed, the interpretation of antimutagenicity data from short-term tests must be subjected to all of the considerations that apply in the interpretation of mutagenicity test results. Moreover, the experimental variable of the antimutagens used must be considered in addition to the variables of the mutagens and short-term tests used. To analyse published results on antimutagens in short-term tests, we have developed the concept of activity profile listings and plots for antimutagens - an approach already used successfully for mutagenicity data. The activity profiles permit rapid visualization of considerable data and experimental parameters, including the inhibition as well as enhancement of mutagenic activity. Here we focus on the use of this methodology to interpret antimutagenicity data for retinol and chlorophyllin against several classes of mutagens in short-term tests.

摘要

那些已被广泛用于识别诱变剂和潜在致癌物的短期测试,越来越多地被用于识别抗诱变剂和潜在抗癌剂。目前尚不清楚致癌物诱导的突变抑制是否是抗癌性的良好指标,因为关于体内致癌性和诱变性抑制的现有数据仍然相当不完整。此外,体外测试只能检测那些在体外显示出可证明效果的化合物,例如直接抑制致癌物的代谢或通过直接反应使致癌物失活。因此,通过使用动物模型来确认体外观察到的假定抗诱变活性至关重要。事实上,对短期测试中抗诱变数据的解释必须考虑到适用于诱变测试结果解释的所有因素。此外,除了所使用的诱变剂和短期测试的变量外,还必须考虑所使用的抗诱变剂的实验变量。为了分析短期测试中关于抗诱变剂的已发表结果,我们开发了抗诱变剂活性谱列表和绘图的概念——一种已成功用于诱变性数据的方法。活性谱允许快速直观地呈现大量数据和实验参数,包括诱变活性的抑制以及增强。在这里,我们重点介绍使用这种方法来解释视黄醇和叶绿酸在短期测试中对几类诱变剂的抗诱变数据。

相似文献

1
Interpretation of short-term test data: implications for assessment of chemopreventive activity.短期试验数据的解读:对化学预防活性评估的意义
IARC Sci Publ. 1996(139):313-32.
2
Antimutagenicity profiles for some model compounds.某些模型化合物的抗诱变特性
Mutat Res. 1990 Jan;238(1):57-85. doi: 10.1016/0165-1110(90)90039-e.
3
Mechanistic considerations in the evaluation of chemopreventive data.化学预防数据评估中的机制性考量
IARC Sci Publ. 1996(139):203-19.
4
Short-term tests for defining mutagenic carcinogens.用于定义诱变致癌物的短期试验。
IARC Sci Publ. 1999(146):499-536.
5
Antimutagens as cancer chemopreventive agents in the diet.作为饮食中癌症化学预防剂的抗诱变剂。
Mutat Res. 1994 May 1;307(1):395-410. doi: 10.1016/0027-5107(94)90313-1.
6
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
7
Effect of five dietary antimutagens on the genotoxicity of six mutagens in the microscreen prophage-induction assay.五种膳食抗诱变剂对微筛前噬菌体诱导试验中六种诱变剂遗传毒性的影响。
Environ Mol Mutagen. 2000;36(3):206-20.
8
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.一组三项体外遗传毒性试验鉴别啮齿动物致癌物和非致癌物能力的评估I. 敏感性、特异性和相对预测性
Mutat Res. 2005 Jul 4;584(1-2):1-256. doi: 10.1016/j.mrgentox.2005.02.004.
9
Anticarcinogenicity of monocyclic phenolic compounds.单环酚类化合物的抗癌性
Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S101-7.
10
Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.遗传毒性测试策略:与体外测试相关的危害识别和风险评估
Mutat Res. 2007 Feb 3;627(1):41-58. doi: 10.1016/j.mrgentox.2006.10.003. Epub 2006 Nov 27.